HIRA clarifies screening results of cholesterol-lowering agents

Published: 2008-11-21 07:00:00

Updated: 2008-11-21 07:00:00

The Health Insurance Review and Assessment Service (HIRA) reaffirmed its position over the results of lipid-lowering medicines, saying its assessment was made based on their clinical and cost effectiveness profiles.

The HIRA said that as the cholesterol-lowering effect of atorvastatin 10 mg is in the range of simvastatin 20-40mg, the price of atorvastatin 10 mg should be determined in simvas...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.